BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32993026)

  • 21. Plasminogen activator inhibitor-1 in aging.
    Yamamoto K; Takeshita K; Saito H
    Semin Thromb Hemost; 2014 Sep; 40(6):652-9. PubMed ID: 25122500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis].
    Bajou K
    Bull Mem Acad R Med Belg; 2002; 157(5-6):313-8. PubMed ID: 12557575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of plasminogen activator inhibitor 1 action in stromal remodeling and related diseases.
    Milenkovic J; Milojkovic M; Jevtovic Stoimenov T; Djindjic B; Miljkovic E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Dec; 161(4):339-347. PubMed ID: 29097819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of fibrosis in muscular dystrophy.
    Smith LR; Barton ER
    Matrix Biol; 2018 Aug; 68-69():602-615. PubMed ID: 29408413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders.
    Yamamoto K; Saito H
    Int J Hematol; 1998 Dec; 68(4):371-85. PubMed ID: 9885437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.
    Philippou A; Maridaki M; Koutsilieris M
    In Vivo; 2008; 22(6):735-50. PubMed ID: 19181000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.
    Arteel GE
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1(Suppl 1):S54-9. PubMed ID: 18336665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of urokinase type plasminogen activator and plasminogen activator inhibitor-1 expressions on the formation of aneurysm of perimembranous ventricular septal defect].
    Qian J; Li B; Yin M; Shen P; Sun K
    Zhonghua Er Ke Za Zhi; 2015 Jun; 53(6):453-8. PubMed ID: 26310557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fracture healing in mice deficient in plasminogen activator inhibitor-1.
    Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH
    Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal fibrosis: not just PAI-1 in the sky.
    Fogo AB
    J Clin Invest; 2003 Aug; 112(3):326-8. PubMed ID: 12897200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma.
    Eitzman DT; Krauss JC; Shen T; Cui J; Ginsburg
    Blood; 1996 Jun; 87(11):4718-22. PubMed ID: 8639841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR; Church FC
    Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts.
    Wu Y; Zhang Q; Ann DK; Akhondzadeh A; Duong HS; Messadi DV; Le AD
    Am J Physiol Cell Physiol; 2004 Apr; 286(4):C905-12. PubMed ID: 14644771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
    Nam TJ; Busby W; Clemmons DR
    Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?
    De Taeye B; Gils A; Declerck PJ
    Thromb Haemost; 2004 Nov; 92(5):898-924. PubMed ID: 15543316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-enolase plasminogen receptor in myogenesis.
    Lopez-Alemany R; Suelves M; Diaz-Ramos A; Vidal B; Munoz-Canoves P
    Front Biosci; 2005 Jan; 10():30-6. PubMed ID: 15574344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.